135 related articles for article (PubMed ID: 20052511)
1. Anti-cyclic citrulline peptide antibody in non-tuberculous mycobacteria sera: a negative association.
Lim MK; Shim TS; Sheen DH; Na DJ; Min SS; Shim SC
Clin Rheumatol; 2010 Mar; 29(3):335-6. PubMed ID: 20052511
[No Abstract] [Full Text] [Related]
2. Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.
Valour F; Perpoint T; Sénéchal A; Kong XF; Bustamante J; Ferry T; Chidiac C; Ader F;
Emerg Infect Dis; 2016 Jun; 22(6):1124-1126. PubMed ID: 27192204
[No Abstract] [Full Text] [Related]
3. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
[TBL] [Abstract][Full Text] [Related]
4. Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria.
Kim K; Waterer G; Thomson R; Yang IA; Nashi N; Tan DB; Price P
Cytokine; 2014 Apr; 66(2):160-3. PubMed ID: 24508556
[TBL] [Abstract][Full Text] [Related]
5. Host Immune Response and Novel Diagnostic Approach to NTM Infections.
Abe Y; Fukushima K; Hosono Y; Matsumoto Y; Motooka D; Ose N; Nakamura S; Kitada S; Kida H; Kumanogoh A
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570978
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections.
Chi CY; Lin CH; Ho MW; Ding JY; Huang WC; Shih HP; Yeh CF; Fung CP; Sun HY; Huang CT; Wu TS; Chang CY; Liu YM; Feng JY; Wu WK; Wang LS; Tsai CH; Ho CM; Lin HS; Chen HJ; Lin PC; Liao WC; Chen WT; Lo CC; Wang SY; Kuo CY; Lee CH; Ku CL
Medicine (Baltimore); 2016 Jun; 95(25):e3927. PubMed ID: 27336882
[TBL] [Abstract][Full Text] [Related]
8. Immune response to atypical mycobacteria.
Appelberg R
Res Immunol; 1996; 147(8-9):560-4. PubMed ID: 9127888
[No Abstract] [Full Text] [Related]
9. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
[TBL] [Abstract][Full Text] [Related]
10. Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.
Suárez I; Lehmann C; Gruell H; Graeb J; Kochanek M; Fätkenheuer G; Plum G; van Wengen A; van de Vosse E; Hartmann P; Hanitsch LG; Rybniker J
Clin Infect Dis; 2017 Aug; 65(3):518-521. PubMed ID: 28430999
[TBL] [Abstract][Full Text] [Related]
11. Immunogenic behaviour of Mycobacterium marinum (SATO) in mice.
Srivastava K; Singh NB
Indian J Med Res; 1986 Nov; 84():485-91. PubMed ID: 3557568
[No Abstract] [Full Text] [Related]
12. Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
Tanaka S; Hoshino Y; Sakagami T; Fukano H; Matsui Y; Hiranuma O
BMC Infect Dis; 2019 May; 19(1):454. PubMed ID: 31117976
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations of nontuberculous mycobacteria.
Heyderman RS; Clark J
Adv Exp Med Biol; 2006; 582():167-77. PubMed ID: 16802627
[No Abstract] [Full Text] [Related]
14. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
[TBL] [Abstract][Full Text] [Related]
15. Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection.
Krisnawati DI; Liu YC; Lee YJ; Wang YT; Chen CL; Tseng PC; Lin CF
Sci Rep; 2019 Apr; 9(1):5682. PubMed ID: 30952894
[TBL] [Abstract][Full Text] [Related]
16. Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.
Shah JA; Lindestam Arlehamn CS; Horne DJ; Sette A; Hawn TR
J Infect Dis; 2019 Aug; 220(7):1091-1098. PubMed ID: 31165861
[TBL] [Abstract][Full Text] [Related]
17. Anti-Interferon Gamma Autoantibody and Disseminated Nontuberculous Mycobacteria Infection: What Should Be Done to Improve Its Clinical Outcome?
Koizumi Y; Mikamo H
Clin Infect Dis; 2021 Jun; 72(12):2209-2211. PubMed ID: 32745203
[No Abstract] [Full Text] [Related]
18. Non-tuberculous mycobacteria and their surface lipids efficiently induced IL-17 production in human T cells.
Jönsson B; Ridell M; Wold AE
Microbes Infect; 2012 Nov; 14(13):1186-95. PubMed ID: 22939918
[TBL] [Abstract][Full Text] [Related]
19. Profiling serum antibodies to Mycobacterium tuberculosis proteins in rhesus monkeys with nontuberculous Mycobacteria.
Min F; Pan J; Wu R; Chen M; Kuang H; Zhao W
Exp Anim; 2016; 65(1):11-6. PubMed ID: 26437786
[TBL] [Abstract][Full Text] [Related]
20. Atypical mycobacteria.
Owens DW
Int J Dermatol; 1978 Apr; 17(3):180-5. PubMed ID: 348619
[No Abstract] [Full Text] [Related]
[Next] [New Search]
